Levels of inflammatory markers (CRP, TNF-α, IL-10) were lower in the treatment group than in the control group (p < 0.01). In both groups, levels of Lactobailli were increased, and Enterococci with Peptococcus decreased. Probiotics with glucorticoids reduced the incidence of infection, abdominal distension, diarrhea, and other side effects. This evidence concerns the gene TNF and infection.